ATAZANAVIR
- Product NDC
- 70518-2832
- 11-digit product format
- 705182832
- Labeler code
- 70518
- Product ID
- 70518-2832_d76fb938-efeb-67a9-e053-2995a90a7cfc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA200626
- Marketing category
- ANDA
- Marketing start
- 2020-08-10
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2832-0 | 70518283200 | 30 CAPSULE, GELATIN COATED in 1 BLISTER PACK (70518-2832-0) | 2020-08-10 | 0000-00-00 | No | No | Current |